Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Ordinary Shares, $0.01 par value per share
-
Shares outstanding
-
29M
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
367K
-
Shares change
-
+181K
-
Total reported value, excl. options
-
$393K
-
Value change
-
+$195K
-
Number of buys
-
4
-
Number of sells
-
-4
-
Price
-
$1.07
Significant Holders of Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share (ITRM) as of Q2 2023
16 filings reported holding ITRM - Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share as of Q2 2023.
Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share (ITRM) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 367K shares
of 29M outstanding shares and own 1.27% of the company stock.
Largest 10 shareholders include Apollon Wealth Management, LLC (200K shares), New Leaf Venture Partners, L.L.C. (97.1K shares), RENAISSANCE TECHNOLOGIES LLC (42.8K shares), MORGAN STANLEY (14K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (13.2K shares), Kelly Financial Services LLC (120 shares), NewEdge Advisors, LLC (100 shares), WELLS FARGO & COMPANY/MN (85 shares), UBS Group AG (48 shares), and Tower Research Capital LLC (TRC) (32 shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.